TNF and severe acute respiratory syndrome: In cases of COVID-19, the SARS-CoV-2 virus promotes an inflammatory response in the lung parenchyma that is characteristic of the pathology of SARS and is mediated by the cytokine interleukin-1β (IL), which is activated by the inflammasome complex IL-6 and tumoral necrosis factor-alpha (TNF).